← Back to Search

Usual care control for Coronavirus

N/A
Waitlist Available
Led By Elsie Taveras, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants are patients at the intervention or control CHCs or members of the local community. The participating sites constitute one group; a set of matched control CHCs that will conduct testing as usual constitute the second group.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 85 weeks post-implementation compared to 35 weeks pre-implementation
Awards & highlights

Study Summary

This study is evaluating whether a new test for HIV may be more effective in certain populations.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~85 weeks post-implementation compared to 35 weeks pre-implementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 85 weeks post-implementation compared to 35 weeks pre-implementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage Change in Testing During the Study Compared to Tests Completed Prior to Study Start

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual care controlExperimental Treatment1 Intervention
Group II: RADx CHCs testing intervention strategyExperimental Treatment1 Intervention
Six Massachusetts community health center partnerships implementing both a common testing expansion implementation strategy plus tailored strategies designed for community partner needs.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,663 Previous Clinical Trials
40,925,899 Total Patients Enrolled
Dana-Farber Cancer InstituteOTHER
1,079 Previous Clinical Trials
340,980 Total Patients Enrolled
Harvard School of Public Health (HSPH)OTHER
272 Previous Clinical Trials
16,305,019 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Implementation of COVID-19 Testing Strategies in Community Health Centers
Elsie Taveras, MD 2020. "Implementation of COVID-19 Testing Strategies in Community Health Centers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04802187.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top